
    
      Consecutive outpatient infants (0 - 6 months) with common cold symptoms were enrolled and
      randomly divided into two groups: resveratrol plus carboxymethyl-Î²-glucan solution or saline
      isotonic solution randomized treatment (3 drops in each nasal fossa, 4 time daily for seven
      days).

      Each patient underwent clinical evaluation at enrollment, after 48 hours and after 7 and 30
      days.

      Common cold symptoms were specifically evaluated according to CARIFS Scale. Nasal swabs for
      HRV research will performed at enrollment, after 48 hours and after 7 and 30 days.
    
  